Name: Latest research reports of Alkem Laboratories Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Alkem Laboratories Ltd.
Rating: 1
Author: BOB Capital Markets Ltd.

Alkem Laboratories Ltd.

NSE: ALKEM | BSE: 539523 | ISIN: INE540L01014 | Industry: Pharmaceuticals
| Mid-range Performer

5448.0000 -11.50 (-0.21%)

NSE Oct 03, 2025 13:20 PM

Volume: 68,151

Alkem Laboratories Ltd.

20 May 2023

5448.00

-0.21%

Alkem Labs (SELL): Margin improvement key for revival

Sell: Alkem Laboratories Ltd.

BOB Capital Markets Ltd.

Q4 EBITDA/PAT of Rs 3.5bn/Rs 710mn well short of consensus by 21%/ 79% primarily due to higher operating costs

Number of FII/FPI investors increased from 535 to 551 in Jun 2025 qtr.